APO Research

APO RESEARCH · REPORT

Azacitidine Injection

Selected research

Industry Growth & Trends

Global Azacitidine Injection Industry Growth and Trends Forecast to 2032

Market perspective

The global Azacitidine Injection market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Azacitidine Injection is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Azacitidine Injection is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Azacitidine Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Azacitidine Injection include Accord Healthcare, Celgene, Dr. Reddy's Laboratories, Eurohealth, Natco Pharma, Shilpa Medicare, Hansoh Pharma, Huiyu Pharmaceutital and Mylan, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Azacitidine Injection market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Azacitidine Injection market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Azacitidine Injection market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Azacitidine Injection.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Azacitidine Injection market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Azacitidine Injection Market by Company

Accord Healthcare

Celgene

Dr. Reddy's Laboratories

Eurohealth

Natco Pharma

Shilpa Medicare

Hansoh Pharma

Huiyu Pharmaceutital

Mylan

CTTQ

Azacitidine Injection Segment by Type

50mg

100mg

Azacitidine Injection Segment by Application

Chronic Myelomonocytic Leukemia (CMML)

Acute Myeloid Leukemia (AML)

Higher-risk myelodysplastic syndromes (MDS)

Others

Azacitidine Injection Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Azacitidine Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Azacitidine Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Azacitidine Injection.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Azacitidine Injection manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Azacitidine Injection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of 50mg Table 2. Major Company of 100mg Table 3. Global Azacitidine Injection Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Azacitidine Injection Sales by Type (2021-2026) & (K Units) Table 5. Global Azacitidine Injection Sales Market Share in Volume by Type (2021-2026) Table 6. Global Azacitidine Injection Sales by Type (2021-2026) & (US$ Million) Table 7. Global Azacitidine Injection Sales Market Share in Value by Type (2021-2026) Table 8. Global Azacitidine Injection Price by Type (2021-2026) & (US$/Unit) Table 9. Global Azacitidine Injection Sales by Type (2027-2032) & (K Units) Table 10. Global Azacitidine Injection Sales Market Share in Volume by Type (2027-2032) Table 11. Global Azacitidine Injection Sales by Type (2027-2032) & (US$ Million) Table 12. Global Azacitidine Injection Sales Market Share in Value by Type (2027-2032) Table 13. Global Azacitidine Injection Price by Type (2027-2032) & (US$/Unit) Table 14. North America Azacitidine Injection Sales by Type (2021-2026) & (K Units) Table 15. North America Azacitidine Injection Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Azacitidine Injection Sales by Type (2021-2026) & (K Units) Table 17. Europe Azacitidine Injection Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Azacitidine Injection Sales by Type (2021-2026) & (K Units) Table 19. Asia-Pacific Azacitidine Injection Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Azacitidine Injection Sales by Type (2021-2026) & (K Units) Table 21. Latin America Azacitidine Injection Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Azacitidine Injection Sales by Type (2021-2026) & (K Units) Table 23. Middle East and Africa Azacitidine Injection Sales by Type (2021-2026) & (US$ Million) Table 24. Azacitidine Injection Industry Trends Table 25. Azacitidine Injection Industry Drivers Table 26. Azacitidine Injection Industry Opportunities and Challenges Table 27. Azacitidine Injection Industry Restraints Table 28. Global Azacitidine Injection Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Azacitidine Injection Revenue Market Share by Company (2021-2026) Table 30. Global Azacitidine Injection Sales by Company (2021-2026) & (K Units) Table 31. Global Azacitidine Injection Sales Share by Company (2021-2026) Table 32. Global Azacitidine Injection Market Price by Company (2021-2026) & (US$/Unit) Table 33. Global Azacitidine Injection Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Azacitidine Injection Major Company Production Sites and Headquarters Table 35. Global Azacitidine Injection Company, Product Type & Application Table 36. Global Azacitidine Injection Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Azacitidine Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Azacitidine Injection Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Azacitidine Injection Sales by Region (2021-2026) & (K Units) Table 41. Global Azacitidine Injection Sales Market Share in Volume by Region (2021-2026) Table 42. Global Azacitidine Injection Sales by Region (2021-2026) & (US$ Million) Table 43. Global Azacitidine Injection Sales Market Share in Value by Region (2021-2026) Table 44. Global Azacitidine Injection Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 45. Global Azacitidine Injection Sales by Region (2027-2032) & (K Units) Table 46. Global Azacitidine Injection Sales Market Share in Volume by Region (2027-2032) Table 47. Global Azacitidine Injection Sales by Region (2027-2032) & (US$ Million) Table 48. Global Azacitidine Injection Sales Market Share in Value by Region (2027-2032) Table 49. Global Azacitidine Injection Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 50. Global Azacitidine Injection Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Azacitidine Injection Sales by Application (2021-2026) & (K Units) Table 52. Global Azacitidine Injection Sales Market Share in Volume by Application (2021-2026) Table 53. Global Azacitidine Injection Sales by Application (2021-2026) & (US$ Million) Table 54. Global Azacitidine Injection Sales Market Share in Value by Application (2021-2026) Table 55. Global Azacitidine Injection Price by Application (2021-2026) & (US$/Unit) Table 56. Global Azacitidine Injection Sales by Application (2027-2032) & (K Units) Table 57. Global Azacitidine Injection Sales Market Share in Volume by Application (2027-2032) Table 58. Global Azacitidine Injection Sales by Application (2027-2032) & (US$ Million) Table 59. Global Azacitidine Injection Sales Market Share in Value by Application (2027-2032) Table 60. Global Azacitidine Injection Price by Application (2027-2032) & (US$/Unit) Table 61. North America Azacitidine Injection Sales by Application (2021-2026) & (K Units) Table 62. North America Azacitidine Injection Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Azacitidine Injection Sales by Application (2021-2026) & (K Units) Table 64. Europe Azacitidine Injection Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Azacitidine Injection Sales by Application (2021-2026) & (K Units) Table 66. Asia-Pacific Azacitidine Injection Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Azacitidine Injection Sales by Application (2021-2026) & (K Units) Table 68. Latin America Azacitidine Injection Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Azacitidine Injection Sales by Application (2021-2026) & (K Units) Table 70. Middle East and Africa Azacitidine Injection Sales by Application (2021-2026) & (US$ Million) Table 71. Accord Healthcare Company Information Table 72. Accord Healthcare Business Overview Table 73. Accord Healthcare Azacitidine Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. Accord Healthcare Azacitidine Injection Product Portfolio Table 75. Accord Healthcare Recent Development Table 76. Celgene Company Information Table 77. Celgene Business Overview Table 78. Celgene Azacitidine Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. Celgene Azacitidine Injection Product Portfolio Table 80. Celgene Recent Development Table 81. Dr. Reddy's Laboratories Company Information Table 82. Dr. Reddy's Laboratories Business Overview Table 83. Dr. Reddy's Laboratories Azacitidine Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. Dr. Reddy's Laboratories Azacitidine Injection Product Portfolio Table 85. Dr. Reddy's Laboratories Recent Development Table 86. Eurohealth Company Information Table 87. Eurohealth Business Overview Table 88. Eurohealth Azacitidine Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. Eurohealth Azacitidine Injection Product Portfolio Table 90. Eurohealth Recent Development Table 91. Natco Pharma Company Information Table 92. Natco Pharma Business Overview Table 93. Natco Pharma Azacitidine Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. Natco Pharma Azacitidine Injection Product Portfolio Table 95. Natco Pharma Recent Development Table 96. Shilpa Medicare Company Information Table 97. Shilpa Medicare Business Overview Table 98. Shilpa Medicare Azacitidine Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 99. Shilpa Medicare Azacitidine Injection Product Portfolio Table 100. Shilpa Medicare Recent Development Table 101. Hansoh Pharma Company Information Table 102. Hansoh Pharma Business Overview Table 103. Hansoh Pharma Azacitidine Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 104. Hansoh Pharma Azacitidine Injection Product Portfolio Table 105. Hansoh Pharma Recent Development Table 106. Huiyu Pharmaceutital Company Information Table 107. Huiyu Pharmaceutital Business Overview Table 108. Huiyu Pharmaceutital Azacitidine Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 109. Huiyu Pharmaceutital Azacitidine Injection Product Portfolio Table 110. Huiyu Pharmaceutital Recent Development Table 111. Mylan Company Information Table 112. Mylan Business Overview Table 113. Mylan Azacitidine Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 114. Mylan Azacitidine Injection Product Portfolio Table 115. Mylan Recent Development Table 116. CTTQ Company Information Table 117. CTTQ Business Overview Table 118. CTTQ Azacitidine Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 119. CTTQ Azacitidine Injection Product Portfolio Table 120. CTTQ Recent Development Table 121. North America Azacitidine Injection Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 122. North America Azacitidine Injection Sales by Country (2021-2026) & (K Units) Table 123. North America Azacitidine Injection Sales Market Share by Country (2021-2026) Table 124. North America Azacitidine Injection Sales Forecast by Country (2027-2032) & (K Units) Table 125. North America Azacitidine Injection Sales Market Share Forecast by Country (2027-2032) Table 126. North America Azacitidine Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 127. North America Azacitidine Injection Market Size by Country (2021-2026) & (US$ Million) Table 128. North America Azacitidine Injection Market Share by Country (2021-2026) Table 129. North America Azacitidine Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 130. North America Azacitidine Injection Market Share Forecast by Country (2027-2032) Table 131. Europe Azacitidine Injection Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 132. Europe Azacitidine Injection Sales by Country (2021-2026) & (K Units) Table 133. Europe Azacitidine Injection Sales Market Share by Country (2021-2026) Table 134. Europe Azacitidine Injection Sales Forecast by Country (2027-2032) & (K Units) Table 135. Europe Azacitidine Injection Sales Market Share Forecast by Country (2027-2032) Table 136. Europe Azacitidine Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 137. Europe Azacitidine Injection Market Size by Country (2021-2026) & (US$ Million) Table 138. Europe Azacitidine Injection Market Share by Country (2021-2026) Table 139. Europe Azacitidine Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 140. Europe Azacitidine Injection Market Share Forecast by Country (2027-2032) Table 141. Asia-Pacific Azacitidine Injection Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 142. Asia-Pacific Azacitidine Injection Sales by Country (2021-2026) & (K Units) Table 143. Asia-Pacific Azacitidine Injection Sales Market Share by Country (2021-2026) Table 144. Asia-Pacific Azacitidine Injection Sales Forecast by Country (2027-2032) & (K Units) Table 145. Asia-Pacific Azacitidine Injection Sales Market Share Forecast by Country (2027-2032) Table 146. Asia-Pacific Azacitidine Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 147. Asia-Pacific Azacitidine Injection Market Size by Country (2021-2026) & (US$ Million) Table 148. Asia-Pacific Azacitidine Injection Market Share by Country (2021-2026) Table 149. Asia-Pacific Azacitidine Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 150. Asia-Pacific Azacitidine Injection Market Share Forecast by Country (2027-2032) Table 151. Latin America Azacitidine Injection Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 152. Latin America Azacitidine Injection Sales by Country (2021-2026) & (K Units) Table 153. Latin America Azacitidine Injection Sales Market Share by Country (2021-2026) Table 154. Latin America Azacitidine Injection Sales Forecast by Country (2027-2032) & (K Units) Table 155. Latin America Azacitidine Injection Sales Market Share Forecast by Country (2027-2032) Table 156. Latin America Azacitidine Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 157. Latin America Azacitidine Injection Market Size by Country (2021-2026) & (US$ Million) Table 158. Latin America Azacitidine Injection Market Share by Country (2021-2026) Table 159. Latin America Azacitidine Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 160. Latin America Azacitidine Injection Market Share Forecast by Country (2027-2032) Table 161. Middle East and Africa Azacitidine Injection Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 162. Middle East and Africa Azacitidine Injection Sales by Country (2021-2026) & (K Units) Table 163. Middle East and Africa Azacitidine Injection Sales Market Share by Country (2021-2026) Table 164. Middle East and Africa Azacitidine Injection Sales Forecast by Country (2027-2032) & (K Units) Table 165. Middle East and Africa Azacitidine Injection Sales Market Share Forecast by Country (2027-2032) Table 166. Middle East and Africa Azacitidine Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 167. Middle East and Africa Azacitidine Injection Market Size by Country (2021-2026) & (US$ Million) Table 168. Middle East and Africa Azacitidine Injection Market Share by Country (2021-2026) Table 169. Middle East and Africa Azacitidine Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 170. Middle East and Africa Azacitidine Injection Market Share Forecast by Country (2027-2032) Table 171. Key Raw Materials Table 172. Raw Materials Key Suppliers Table 173. Azacitidine Injection Distributors List Table 174. Azacitidine Injection Customers List Table 175. Research Programs/Design for This Report Table 176. Authors List of This Report Table 177. Secondary Sources Table 178. Primary Sources List of Figures Figure 1. Azacitidine Injection Image Figure 2. Global Azacitidine Injection Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Azacitidine Injection Market Size (2021-2032) & (US$ Million) Figure 4. Global Azacitidine Injection Sales (2021-2032) & (K Units) Figure 5. 50mg Image Figure 6. Global 50mg Sales YoY Growth (2021-2032) & (K Units) Figure 7. 100mg Image Figure 8. Global 100mg Sales YoY Growth (2021-2032) & (K Units) Figure 9. Global Azacitidine Injection Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Azacitidine Injection Market Share by Type 2025 VS 2032 Figure 11. North America Azacitidine Injection Sales Market Share in Volume by Type in 2025 Figure 12. North America Azacitidine Injection Sales Market Share in Value by Type in 2025 Figure 13. Europe Azacitidine Injection Sales Market Share in Volume by Type in 2025 Figure 14. Europe Azacitidine Injection Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Azacitidine Injection Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Azacitidine Injection Sales Market Share in Value by Type in 2025 Figure 17. Latin America Azacitidine Injection Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Azacitidine Injection Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Azacitidine Injection Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Azacitidine Injection Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Azacitidine Injection Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Chronic Myelomonocytic Leukemia (CMML) Image Figure 24. Global Chronic Myelomonocytic Leukemia (CMML) Sales YoY Growth (2021-2032) & (K Units) Figure 25. Acute Myeloid Leukemia (AML) Image Figure 26. Global Acute Myeloid Leukemia (AML) Sales YoY Growth (2021-2032) & (K Units) Figure 27. Higher-risk myelodysplastic syndromes (MDS) Image Figure 28. Global Higher-risk myelodysplastic syndromes (MDS) Sales YoY Growth (2021-2032) & (K Units) Figure 29. Others Image Figure 30. Global Others Sales YoY Growth (2021-2032) & (K Units) Figure 31. Global Azacitidine Injection Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global Azacitidine Injection Market Share by Application 2025 VS 2032 Figure 33. North America Azacitidine Injection Sales Market Share in Volume by Application in 2025 Figure 34. North America Azacitidine Injection Sales Market Share in Value by Application in 2025 Figure 35. Europe Azacitidine Injection Sales Market Share in Volume by Application in 2025 Figure 36. Europe Azacitidine Injection Sales Market Share in Value by Application in 2025 Figure 37. Asia-Pacific Azacitidine Injection Sales Market Share in Volume by Application in 2025 Figure 38. Asia-Pacific Azacitidine Injection Sales Market Share in Value by Application in 2025 Figure 39. Latin America Azacitidine Injection Sales Market Share in Volume by Application in 2025 Figure 40. Latin America Azacitidine Injection Sales Market Share in Value by Application in 2025 Figure 41. Middle East and Africa Azacitidine Injection Sales Market Share in Volume by Application in 2025 Figure 42. Middle East and Africa Azacitidine Injection Sales Market Share in Value by Application in 2025 Figure 43. North America Azacitidine Injection Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 44. North America Azacitidine Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. North America Azacitidine Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. North America Azacitidine Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Azacitidine Injection Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 48. Europe Azacitidine Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Azacitidine Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Europe Azacitidine Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Azacitidine Injection Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 52. Asia-Pacific Azacitidine Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Azacitidine Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Asia-Pacific Azacitidine Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Azacitidine Injection Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 56. Latin America Azacitidine Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Azacitidine Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Latin America Azacitidine Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Azacitidine Injection Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 60. Middle East and Africa Azacitidine Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Azacitidine Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Middle East and Africa Azacitidine Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Azacitidine Injection Value Chain Figure 64. Key Raw Materials Price Figure 65. Manufacturing Cost Structure Figure 66. Azacitidine Injection Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • 50mg
  • 100mg
Applications
  • Chronic Myelomonocytic Leukemia (CMML)
  • Acute Myeloid Leukemia (AML)
  • Higher-risk myelodysplastic syndromes (MDS)
  • Others
Companies covered
  • Accord Healthcare
  • Celgene
  • Dr. Reddy's Laboratories
  • Eurohealth
  • Natco Pharma
  • Shilpa Medicare
  • Hansoh Pharma
  • Huiyu Pharmaceutital
  • Mylan
  • CTTQ

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Azacitidine Injection Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Azacitidine Injection Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Azacitidine Injection Market by Type
  6. 1.3.1 50mg
  7. 1.3.2 100mg
  8. 1.4 Global Azacitidine Injection Market Size by Type
  9. 1.4.1 Global Azacitidine Injection Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Azacitidine Injection Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Azacitidine Injection Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Azacitidine Injection Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Azacitidine Injection Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Azacitidine Injection Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Azacitidine Injection Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Azacitidine Injection Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Azacitidine Injection Industry Trends
  2. 2.2 Azacitidine Injection Industry Drivers
  3. 2.3 Azacitidine Injection Industry Opportunities and Challenges
  4. 2.4 Azacitidine Injection Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Azacitidine Injection Revenue (2021-2026)
  2. 3.2 Global Top Players by Azacitidine Injection Sales (2021-2026)
  3. 3.3 Global Top Players by Azacitidine Injection Price (2021-2026)
  4. 3.4 Global Azacitidine Injection Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Azacitidine Injection Major Company Production Sites & Headquarters
  6. 3.6 Global Azacitidine Injection Company, Product Type & Application
  7. 3.7 Global Azacitidine Injection Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Azacitidine Injection Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Azacitidine Injection Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Azacitidine Injection Tier 1, Tier 2, and Tier 3
4 Azacitidine Injection Regional Status and Outlook
  1. 4.1 Global Azacitidine Injection Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Azacitidine Injection Historic Market Size by Region
  3. 4.2.1 Global Azacitidine Injection Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Azacitidine Injection Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Azacitidine Injection Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Azacitidine Injection Forecasted Market Size by Region
  7. 4.3.1 Global Azacitidine Injection Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Azacitidine Injection Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Azacitidine Injection Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Azacitidine Injection by Application
  1. 5.1 Azacitidine Injection Market by Application
  2. 5.1.1 Chronic Myelomonocytic Leukemia (CMML)
  3. 5.1.2 Acute Myeloid Leukemia (AML)
  4. 5.1.3 Higher-risk myelodysplastic syndromes (MDS)
  5. 5.1.4 Others
  6. 5.2 Global Azacitidine Injection Market Size by Application
  7. 5.2.1 Global Azacitidine Injection Market Size Overview by Application (2021-2032)
  8. 5.2.2 Global Azacitidine Injection Historic Market Size Review by Application (2021-2026)
  9. 5.2.3 Global Azacitidine Injection Forecasted Market Size by Application (2027-2032)
  10. 5.3 Key Regions Market Size by Application
  11. 5.3.1 North America Azacitidine Injection Sales Breakdown by Application (2021-2026)
  12. 5.3.2 Europe Azacitidine Injection Sales Breakdown by Application (2021-2026)
  13. 5.3.3 Asia-Pacific Azacitidine Injection Sales Breakdown by Application (2021-2026)
  14. 5.3.4 South America Azacitidine Injection Sales Breakdown by Application (2021-2026)
  15. 5.3.5 Middle East and Africa Azacitidine Injection Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Accord Healthcare
  2. 6.1.1 Accord Healthcare Company Information
  3. 6.1.2 Accord Healthcare Business Overview
  4. 6.1.3 Accord Healthcare Azacitidine Injection Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Accord Healthcare Azacitidine Injection Product Portfolio
  6. 6.1.5 Accord Healthcare Recent Developments
  7. 6.2 Celgene
  8. 6.2.1 Celgene Company Information
  9. 6.2.2 Celgene Business Overview
  10. 6.2.3 Celgene Azacitidine Injection Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Celgene Azacitidine Injection Product Portfolio
  12. 6.2.5 Celgene Recent Developments
  13. 6.3 Dr. Reddy's Laboratories
  14. 6.3.1 Dr. Reddy's Laboratories Company Information
  15. 6.3.2 Dr. Reddy's Laboratories Business Overview
  16. 6.3.3 Dr. Reddy's Laboratories Azacitidine Injection Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Dr. Reddy's Laboratories Azacitidine Injection Product Portfolio
  18. 6.3.5 Dr. Reddy's Laboratories Recent Developments
  19. 6.4 Eurohealth
  20. 6.4.1 Eurohealth Company Information
  21. 6.4.2 Eurohealth Business Overview
  22. 6.4.3 Eurohealth Azacitidine Injection Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Eurohealth Azacitidine Injection Product Portfolio
  24. 6.4.5 Eurohealth Recent Developments
  25. 6.5 Natco Pharma
  26. 6.5.1 Natco Pharma Company Information
  27. 6.5.2 Natco Pharma Business Overview
  28. 6.5.3 Natco Pharma Azacitidine Injection Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Natco Pharma Azacitidine Injection Product Portfolio
  30. 6.5.5 Natco Pharma Recent Developments
  31. 6.6 Shilpa Medicare
  32. 6.6.1 Shilpa Medicare Company Information
  33. 6.6.2 Shilpa Medicare Business Overview
  34. 6.6.3 Shilpa Medicare Azacitidine Injection Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Shilpa Medicare Azacitidine Injection Product Portfolio
  36. 6.6.5 Shilpa Medicare Recent Developments
  37. 6.7 Hansoh Pharma
  38. 6.7.1 Hansoh Pharma Company Information
  39. 6.7.2 Hansoh Pharma Business Overview
  40. 6.7.3 Hansoh Pharma Azacitidine Injection Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Hansoh Pharma Azacitidine Injection Product Portfolio
  42. 6.7.5 Hansoh Pharma Recent Developments
  43. 6.8 Huiyu Pharmaceutital
  44. 6.8.1 Huiyu Pharmaceutital Company Information
  45. 6.8.2 Huiyu Pharmaceutital Business Overview
  46. 6.8.3 Huiyu Pharmaceutital Azacitidine Injection Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Huiyu Pharmaceutital Azacitidine Injection Product Portfolio
  48. 6.8.5 Huiyu Pharmaceutital Recent Developments
  49. 6.9 Mylan
  50. 6.9.1 Mylan Company Information
  51. 6.9.2 Mylan Business Overview
  52. 6.9.3 Mylan Azacitidine Injection Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Mylan Azacitidine Injection Product Portfolio
  54. 6.9.5 Mylan Recent Developments
  55. 6.10 CTTQ
  56. 6.10.1 CTTQ Company Information
  57. 6.10.2 CTTQ Business Overview
  58. 6.10.3 CTTQ Azacitidine Injection Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 CTTQ Azacitidine Injection Product Portfolio
  60. 6.10.5 CTTQ Recent Developments
7 North America by Country
  1. 7.1 North America Azacitidine Injection Sales by Country
  2. 7.1.1 North America Azacitidine Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Azacitidine Injection Sales by Country (2021-2026)
  4. 7.1.3 North America Azacitidine Injection Sales Forecast by Country (2027-2032)
  5. 7.2 North America Azacitidine Injection Market Size by Country
  6. 7.2.1 North America Azacitidine Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Azacitidine Injection Market Size by Country (2021-2026)
  8. 7.2.3 North America Azacitidine Injection Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Azacitidine Injection Sales by Country
  2. 8.1.1 Europe Azacitidine Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Azacitidine Injection Sales by Country (2021-2026)
  4. 8.1.3 Europe Azacitidine Injection Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Azacitidine Injection Market Size by Country
  6. 8.2.1 Europe Azacitidine Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Azacitidine Injection Market Size by Country (2021-2026)
  8. 8.2.3 Europe Azacitidine Injection Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Azacitidine Injection Sales by Country
  2. 9.1.1 Asia-Pacific Azacitidine Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Azacitidine Injection Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Azacitidine Injection Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Azacitidine Injection Market Size by Country
  6. 9.2.1 Asia-Pacific Azacitidine Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Azacitidine Injection Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Azacitidine Injection Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Azacitidine Injection Sales by Country
  2. 10.1.1 South America Azacitidine Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Azacitidine Injection Sales by Country (2021-2026)
  4. 10.1.3 South America Azacitidine Injection Sales Forecast by Country (2027-2032)
  5. 10.2 South America Azacitidine Injection Market Size by Country
  6. 10.2.1 South America Azacitidine Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Azacitidine Injection Market Size by Country (2021-2026)
  8. 10.2.3 South America Azacitidine Injection Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Azacitidine Injection Sales by Country
  2. 11.1.1 Middle East and Africa Azacitidine Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Azacitidine Injection Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Azacitidine Injection Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Azacitidine Injection Market Size by Country
  6. 11.2.1 Middle East and Africa Azacitidine Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Azacitidine Injection Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Azacitidine Injection Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Azacitidine Injection Value Chain Analysis
  2. 12.1.1 Azacitidine Injection Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Azacitidine Injection Production Mode & Process
  7. 12.2 Azacitidine Injection Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Azacitidine Injection Distributors
  10. 12.2.3 Azacitidine Injection Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research